TILDRAKIZUMAB for Lichen planus: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where TILDRAKIZUMAB was used for Lichen planus.
Most Reported Side Effects for TILDRAKIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product dose omission issue | 53 | 6.1% | 7 | 12 |
| Death | 50 | 5.8% | 50 | 7 |
| Drug ineffective | 50 | 5.8% | 2 | 9 |
| Psoriasis | 37 | 4.3% | 3 | 12 |
| Urinary tract infection | 36 | 4.1% | 1 | 11 |
| Pneumonia | 33 | 3.8% | 3 | 22 |
| Off label use | 27 | 3.1% | 0 | 2 |
| Condition aggravated | 25 | 2.9% | 0 | 5 |
| Covid-19 | 25 | 2.9% | 3 | 15 |
| Inappropriate schedule of product administration | 22 | 2.5% | 3 | 6 |
| Cerebrovascular accident | 20 | 2.3% | 0 | 15 |
| Fatigue | 17 | 2.0% | 2 | 4 |
| Myocardial infarction | 17 | 2.0% | 4 | 11 |
| Cellulitis | 16 | 1.8% | 0 | 6 |
| Pruritus | 16 | 1.8% | 1 | 6 |
Other Indications for TILDRAKIZUMAB
Psoriasis (644)
Product used for unknown indication (176)
Psoriatic arthropathy (30)
Hidradenitis (8)
Other Drugs Used for Lichen planus
METHOTREXATE (98)
HYDROXYCHLOROQUINE (90)
MYCOPHENOLATE MOFETIL (78)
DUPILUMAB (77)
APREMILAST (75)
CYCLOSPORINE (75)
TACROLIMUS (62)
ACITRETIN (54)
PREDNISONE (51)
CLOBETASOL (50)